ALLERGIC CONJUNCTIVITIS Components of allergy can exist alone or in combination with others, to include allergic rhinitis, allergic conjunctivitis, allergic sinusitis, allergic dermatitis, and ...

This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. In 1999, I defined ...

This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. In 1999, I defined ...

There are several OTC therapies available to combat allergic conjunctivitis. The topical ophthalmic H1 antihistamines have a more rapid onset of action than oral H1 antihistamines but require more ...

Mordor Intelligence has published a new report on the conjunctivitis treatment market, offering a comprehensive analysis of trends, growth drivers, and future projections.

Please provide your email address to receive an email when new articles are posted on . WASHINGTON — Patients who underwent Dextenza implantation had improvements in itching due to allergic ...

Do not wear contact lenses during treatment. To prevent contamination, the dropper tip should not touch the eyelids or surrounding areas. Keep the bottle tightly closed when not in use. All products ...

Aldeyra Therapeutics Inc.’s stock ALDX jumped 11% premarket Thursday, after the biotech announced positive results from a late-stage trial of a treatment for allergic conjunctivitis. The Lexington, ...

LEXINGTON, Mass.--(BUSINESS WIRE)--Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) today announced completion of enrollment in the Phase 3 INVIGORATE-2 clinical trial of topical ocular reproxalap, ...

Please provide your email address to receive an email when new articles are posted on . The FDA has approved an investigational new drug application for the evaluation of VSJ-110, a cystic fibrosis ...

BEDFORD, Mass.--(BUSINESS WIRE)--Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases ...

Oral second-generation antihistamines are considered first-line therapy for allergic rhinitis but are not indicated for nonallergic vasomotor rhinitis. 1 Intranasal antihistamines can also be ...